1. Home
  2. GTEC vs UBX Comparison

GTEC vs UBX Comparison

Compare GTEC & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTEC
  • UBX
  • Stock Information
  • Founded
  • GTEC 2006
  • UBX 2009
  • Country
  • GTEC United States
  • UBX United States
  • Employees
  • GTEC N/A
  • UBX N/A
  • Industry
  • GTEC Industrial Machinery/Components
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GTEC Industrials
  • UBX Health Care
  • Exchange
  • GTEC Nasdaq
  • UBX Nasdaq
  • Market Cap
  • GTEC 32.2M
  • UBX 29.2M
  • IPO Year
  • GTEC N/A
  • UBX 2018
  • Fundamental
  • Price
  • GTEC $2.33
  • UBX $2.22
  • Analyst Decision
  • GTEC
  • UBX Strong Buy
  • Analyst Count
  • GTEC 0
  • UBX 2
  • Target Price
  • GTEC N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • GTEC 373.9K
  • UBX 483.8K
  • Earning Date
  • GTEC 11-14-2024
  • UBX 11-04-2024
  • Dividend Yield
  • GTEC N/A
  • UBX N/A
  • EPS Growth
  • GTEC N/A
  • UBX N/A
  • EPS
  • GTEC N/A
  • UBX N/A
  • Revenue
  • GTEC $87,352,614.00
  • UBX N/A
  • Revenue This Year
  • GTEC N/A
  • UBX N/A
  • Revenue Next Year
  • GTEC $1.70
  • UBX $33.62
  • P/E Ratio
  • GTEC N/A
  • UBX N/A
  • Revenue Growth
  • GTEC 0.76
  • UBX N/A
  • 52 Week Low
  • GTEC $1.36
  • UBX $0.94
  • 52 Week High
  • GTEC $3.69
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • GTEC 52.19
  • UBX 61.12
  • Support Level
  • GTEC $2.23
  • UBX $2.02
  • Resistance Level
  • GTEC $2.78
  • UBX $2.42
  • Average True Range (ATR)
  • GTEC 0.32
  • UBX 0.31
  • MACD
  • GTEC -0.01
  • UBX 0.01
  • Stochastic Oscillator
  • GTEC 37.23
  • UBX 39.61

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: